You are here

Suppressor alphabeta T lymphocytes control innate resistance to endotoxic shock.

TitleSuppressor alphabeta T lymphocytes control innate resistance to endotoxic shock.
Publication TypeJournal Article
Year of Publication2005
AuthorsJones-Carson, J, Fantuzzi, G, Siegmund, B, Dinarello, C, Tracey, KJ, Wang, H, Fang, FC, Vazquez-Torres, A
JournalJ Infect Dis
Volume192
Issue6
Pagination1039-46
Date Published2005 Sep 15
ISSN0022-1899
KeywordsAnimals, Disease Models, Animal, Endotoxemia, Immunity, Innate, Lipopolysaccharides, Mice, Mice, Inbred C57BL, Receptors, Antigen, T-Cell, alpha-beta, Shock, Septic, Survival Analysis, T-Lymphocytes, Regulatory, Transforming Growth Factor beta, Tumor Necrosis Factor-alpha
Abstract

A considerable amount of research has focused on elucidating the mechanisms by which cytokines synthesized by cells of the innate immune system participate in the life-threatening multiple-organ failure of endotoxic shock. We show here that alphabeta T cells, which are archetypes of the adaptive cellular immune response, suppress the proinflammatory cascade triggered during the early stages of lipopolysaccharide (LPS)-induced endotoxemia. The absence of alphabeta T cells led to the fulminant death of LPS-challenged mice, coinciding with a massive release of the proinflammatory cytokines tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma and a marked reduction in the synthesis of the immunosuppressive cytokine transforming growth factor (TGF)-beta. Cytotoxic T lymphocyte antigen (CTLA)-positive alphabeta T cells emerging shortly after LPS challenge appear to control TGF-beta synthesis. The neutralization of either TGF-beta or CTLA4 resulted in similar increases in IFN-gamma and TNF-alpha serum concentrations in LPS-challenged mice. These observations suggest that suppressor alphabeta T lymphocytes protect against the proinflammatory cascade unleashed during the innate stages of endotoxemia.

DOI10.1086/432727
Alternate JournalJ. Infect. Dis.
PubMed ID16107957
Grant ListAI10181 / AI / NIAID NIH HHS / United States
AI15614 / AI / NIAID NIH HHS / United States
AI39557 / AI / NIAID NIH HHS / United States
AI54959 / AI / NIAID NIH HHS / United States
DK061483 / DK / NIDDK NIH HHS / United States
HL68743 / HL / NHLBI NIH HHS / United States
R01 GM057226 / GM / NIGMS NIH HHS / United States